MediXall Group, Inc. (MDXL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -6.52 Million USD | 3.72% |
| 2021 | -6.12 Million USD | -10.12% |
| 2020 | -5.92 Million USD | -76.9% |
| 2019 | -3.41 Million USD | -19.38% |
| 2018 | -2.89 Million USD | -71.38% |
| 2017 | -1.55 Million USD | -149.23% |
| 2016 | - USD | -88.5% |
| 2015 | - USD | 49.04% |
| 2014 | -684.08 Thousand USD | 30.13% |
| 2013 | -979.06 Thousand USD | -475.92% |
| 2012 | -170 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -932.12 Thousand USD | 16.41% |
| 2023 Q1 | -1.11 Million USD | 24.51% |
| 2023 Q3 | -741.85 Thousand USD | 20.41% |
| 2022 Q2 | -1.55 Million USD | 35.49% |
| 2022 Q4 | -1.47 Million USD | -36.29% |
| 2022 Q3 | -1.08 Million USD | 30.21% |
| 2022 FY | - USD | 3.72% |
| 2022 Q1 | -2.4 Million USD | -21.38% |
| 2021 Q3 | -1.39 Million USD | 16.12% |
| 2021 Q4 | -1.98 Million USD | -42.68% |
| 2021 FY | - USD | -10.12% |
| 2021 Q1 | -1.33 Million USD | 32.33% |
| 2021 Q2 | -1.65 Million USD | -24.49% |
| 2020 Q2 | -1.14 Million USD | 38.11% |
| 2020 FY | - USD | -76.9% |
| 2020 Q3 | -965.63 Thousand USD | 15.67% |
| 2020 Q4 | -1.96 Million USD | -103.73% |
| 2020 Q1 | -1.85 Million USD | -51.11% |
| 2019 Q3 | -713.87 Thousand USD | -6.65% |
| 2019 Q4 | -1.22 Million USD | -71.51% |
| 2019 FY | - USD | -19.38% |
| 2019 Q1 | -743.39 Thousand USD | -39.34% |
| 2019 Q2 | -669.36 Thousand USD | 9.96% |
| 2018 Q2 | -615.06 Thousand USD | 39.15% |
| 2018 Q3 | -734.16 Thousand USD | -19.36% |
| 2018 Q4 | -533.51 Thousand USD | 27.33% |
| 2018 FY | - USD | -71.38% |
| 2018 Q1 | -1.01 Million USD | -89.95% |
| 2017 FY | - USD | -149.23% |
| 2017 Q4 | -532.18 Thousand USD | -54.8% |
| 2017 Q3 | -343.78 Thousand USD | 8.59% |
| 2017 Q2 | -376.06 Thousand USD | 3.28% |
| 2017 Q1 | -388.82 Thousand USD | 22.96% |
| 2016 Q3 | -52.24 Thousand USD | -30.97% |
| 2016 FY | - USD | -88.5% |
| 2016 Q4 | -504.73 Thousand USD | -866.01% |
| 2016 Q2 | -39.89 Thousand USD | 33.83% |
| 2016 Q1 | -60.28 Thousand USD | -173.15% |
| 2015 FY | - USD | 49.04% |
| 2015 Q4 | -22.07 Thousand USD | 82.81% |
| 2015 Q3 | -128.36 Thousand USD | -18.9% |
| 2015 Q2 | -107.95 Thousand USD | -19.65% |
| 2015 Q1 | -90.22 Thousand USD | -15.11% |
| 2014 Q3 | -157.5 Thousand USD | -80.67% |
| 2014 FY | - USD | 30.13% |
| 2014 Q2 | -87.17 Thousand USD | 49.02% |
| 2014 Q4 | -78.38 Thousand USD | 50.23% |
| 2014 Q1 | -171.01 Thousand USD | 19.54% |
| 2013 Q3 | -532.6 Thousand USD | 0.0% |
| 2013 Q4 | -212.54 Thousand USD | 60.09% |
| 2013 FY | - USD | -475.92% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 21.645% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | -2.84 Million USD | -129.191% |
| Cannabis Sativa, Inc. | -1.11 Million USD | -485.32% |
| CompuMed, Inc. | 690.19 Thousand USD | 1045.185% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 103.066% |
| Cogstate Limited | 9.89 Million USD | 165.953% |
| CareView Communications, Inc. | -210.04 Thousand USD | -3005.861% |
| Craneware plc | 54.26 Million USD | 112.023% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 46.931% |
| Certive Solutions Inc. | -704.66 Thousand USD | -825.772% |
| Drug Free Solution, Inc. | -1.39 Million USD | -367.665% |
| DATATRAK International, Inc. | 2.72 Million USD | 339.086% |
| Strainsforpains, Inc. | -65.61 Thousand USD | -9842.969% |
| Healixa Inc. | -6.32 Million USD | -3.215% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 10.16 Million USD | 164.154% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | -1433.2% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | - USD | Infinity% |
| IQ-AI Limited | -370.35 Thousand USD | -1661.45% |
| Cannabiz Mobile, Inc. | -750.00 USD | -869710.933% |
| Mednow Inc. | -28.12 Million USD | 76.804% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | -2309.689% |
| Mitesco, Inc. | -11.96 Million USD | 45.47% |
| MobileSmith, Inc. | -13.83 Million USD | 52.856% |
| NantHealth, Inc. | -38.53 Million USD | 83.071% |
| Net Medical Xpress Solutions, Inc. | -1.69 Million USD | -284.192% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -12.08 Million USD | 46.026% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 46.079% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 597.326% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 8829.536% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | -53442.203% |
| Renalytix Plc | -28.52 Million USD | 77.127% |
| Revium Recovery Inc. | -678 Thousand USD | -862.18% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | -369.00 USD | -1767808.401% |
| Vaso Corporation | 4.19 Million USD | 255.509% |
| Vynleads, Inc. | -235.72 Thousand USD | -2667.443% |